丸美股份股票讨论区

The trend of falling ROCE at Guangdong Marubi Biotechnology does not inspire confidence. However, the company's growth trends and reinvestment in its operations are encouraging. Despite these positive trends, the stock has fallen 42% over the last three years.

Core point
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...